// App-Quantinova.ai

VPB0843 : The ratio of von Willebrand factor activity to antigen in newly diagnosed essential thrombocythemia

Researchers

Presenter

  • K. Yokoyama

Principal Investigators

  • N/A

Medical Centers

  • Tokai University Hachioji Hospital, Hachioji, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Essential thrombocythemia

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved